Lexaria Bioscience Corp.: Lexaria Welcomes Dr. Catherine Turkel to its Board of Directors
KELOWNA, BC / ACCESSWIRE / September 2, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce that
Source: finanznachrichten.de